NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, NEW
ZEALAND, HONG KONG, JAPAN, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY
OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE
UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO
IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE.

Reference is made to the stock exchange announcement made by Inify Laboratories
AB (the "Company") on 9 January 2025 regarding the commencement of the
subscription period in a fully guaranteed subsequent repair offering of
3,464,300 new shares in the Company (the "Subsequent Offer Shares"), at an offer
price of NOK 4.50 per Subsequent Offer Share, with gross proceeds of NOK
15,589,350 (the "Subsequent Offering").

The subscription period in the Subsequent Offering expired on 23 January 2025 at
16:30 hours (CET). By the end of the subscription period, the Company had
received valid subscriptions for 1,090,861 Subsequent Offer Shares in the
Subsequent Offering. The remaining 2,373,439 Subsequent Offer Shares have been
allocated to the guarantors for the Subsequent Offering.

Monsun AS and Auris AS (the "Guarantors"), companies controlled by the same
owners as the two largest shareholders Gallivant S.à r.l. ("Gallivant") and
Tauri AS ("Tauri"), respectively, have entered into guarantee undertakings (the
"Guarantee Commitment") covering in total 100% of the Subsequent Offering and
the preceding private placement (the "Private Placement"). The Guarantors will
not receive any compensation for the Guarantee Commitment.

The Company's board of directors has resolved to allocate 3,464,300 Subsequent
Offer Shares, in accordance with the allocation criteria set out in the national
prospectus for the Subsequent Offering dated 6 January 2025 (the "Prospectus"),
raising gross proceeds of NOK 15,589,350. 1,090,861 Subsequent Offer Shares were
allocated to Eligible Shareholders (as defined in the Prospectus), and the
remaining 2,373,439 Subsequent Offer Shares were allocated to the Guarantors for
the Subsequent Offering, as follows:

  · Monsun AS: 2,034,376 Subsequent Offer Shares
  · Auris AS: 339,063 Subsequent Offer Shares

Notifications of allocated Subsequent Offer Shares and the corresponding amount
to be paid by each subscriber are expected to be distributed on or about 24
January. The Subsequent Offer Shares will be issued by the board of directors
pursuant to the board authorization to increase the Company's share capital
granted by the extraordinary general meeting of the Company held on 6 December
2024. The due date for payment of the Subsequent Offer Shares is 14 February.
Subject to timely payment of the Subsequent Offer Shares subscribed for and
allocated in the Subsequent Offering, and subject to registration of the capital
increase pertaining to the Subsequent Offering with the Swedish Companies
Registration Office (Sw.: Bolagsverket), the delivery of the Subsequent Offer
Shares is expected to take place on or about 19 February 2025. The Company
assesses that it carries out protection-worthy activities under the Screening of
Foreign Direct Investments Act (the "Swedish FDI Act") and an investment in the
Company may be subject to mandatory filing. If an investment is subject to
mandatory filing, it must prior to its completion, be filed with the
Inspectorate of Strategic Products (the "ISP"). The investor may be imposed an
administrative sanction if an investment that is subject to mandatory filing is
carried out before the ISP has either i) decided to take no action, or ii)
authorized the investment. The allocation of shares and the delivery of the same
(both Subsequent Offer Shares and shares allocated in the Private Placement) to
Monsun AS and Gallivant is conditional upon Monsun AS and Gallivant receiving a
positive decision from the ISP pursuant to the Screening of Foreign Direct
Investment Act. The Subsequent Offer Shares are expected to commence trading on
Euronext Growth Oslo on or about 19 February 2025.

Advisors

SpareBank 1 Markets AS has been appointed as financial advisor in connection
with the Subsequent Offering. Schjødt law firm acts as legal counsel to the
Company.

For further information, please contact CEO, Fredrik Palm,
fredrik.palm@inify.com, or visit https://www.inify.com

###

The future of pathology

Inify Laboratories provides cancer diagnostics through ultramodern laboratory
services within pathology. It uses a fully digital, standardized and AI
-supported workflow to optimize quality and response times, initially within
prostate. The concept is scalable and can be extended to other diagnoses.

The service includes the whole chain of sample handling: from logistics, to
sample preparation, to reporting by a pathologist. The report is assisted by our
own AI, proven in clinical studies to have world-leading accuracy. The complete
workflow is supported by a tailor-made process control system.

The company, based in Sweden, became independent in 2022 through a spin-off from
ContextVision(https://www.contextvision.com/), with 40 years of experience
within digital imaging for medical applications. It is listed on Euronext Growth
Oslo under the ticker INIFY.

This information is subject to the disclosure requirements pursuant to section 5
-12 the Norwegian Securities Trading Act.

Important information

The release, announcement or distribution of this press release may, in certain
jurisdictions, be subject to restrictions. The recipients of this press release
in jurisdictions where this press release has been published or distributed
shall inform themselves of and follow such restrictions. The recipient of this
press release is responsible for using this press release, and the information
contained herein, in accordance with applicable rules in each jurisdiction. The
information in this press release does not contain or constitute an offer to
acquire, subscribe or otherwise trade in shares, subscription rights or other
securities in the Company in any jurisdiction. Any invitation to the persons
concerned to subscribe for shares in the Subsequent Offering will only be made
through the Prospectus.

This press release does not identify or suggest, or purport to identify or
suggest, the risks (direct or indirect) that may be associated with an
investment in new shares. Any investment decision in connection with the
Subsequent Offering must be made on the basis of the information included in the
Prospectus. Such information has not been independently verified by SpareBank 1
Markets. The information contained in this announcement is for background
purposes only and does not purport to be full or complete. No reliance may be
placed for any purpose on the information contained in this announcement or its
accuracy or completeness. SpareBank 1 Markets is acting for the Company in
connection with the transaction and no one else and will not be responsible to
anyone other than the Company for providing the protections afforded to its
clients nor for giving advice in relation to the transaction or any other matter
referred to herein.

This press release does not constitute a recommendation concerning any
investor's option with respect to the Subsequent Offering. Each investor or
prospective investor should conduct his, her or its own investigation, analysis
and evaluation of the business and data described in this announcement and
publicly available information. The price and value of securities can go down as
well as up. Past performance is not a guide to future performance.

The information contained in this press release is not intended for, and must
not be accessed by, or distributed or disseminated, directly or indirectly, in
whole or in part, to persons resident or physically present in the United States
of America (including its territories and possessions, any state of the United
States and the District of Columbia) (the "United States"), Australia, Canada,
Hong Kong, Japan, New Zealand, Singapore, South Africa, United Kingdom or any
other jurisdiction where such action is wholly or partially subject to legal
restrictions, or would require additional prospectuses, registration or other
measures than those required by Norwegian law. The information in the press
release does not constitute any offer regarding subscription rights, paid
subscribed shares or shares in the Company ("Securities") to any person in said
jurisdictions. The information in the press release may not be forwarded or
reproduced in such a manner that contravenes such restrictions or gives cause to
such requirements.

No securities have been or will be registered under the United States Securities
Act of 1933, as amended (the "Securities Act") or the securities legislation of
any state or other jurisdiction in the United States and may not be offered,
subscribed for, exercised, used, pledged, sold, resold, granted, delivered or
otherwise transferred, directly or indirectly, in or into the United States
except pursuant to an applicable exemption from, or in a transaction not subject
to, the registration requirements under the Securities Act and in compliance
with the securities legislation in the relevant state or any other jurisdiction
of the United States.

Within the European Economic Area ("EEA"), no public offering of Securities is
made in other countries than Sweden or Norway. In other member states of the EU,
such an offering of Securities may only be made in accordance with the
Prospectus Regulation (EU) 2017/1129 (the "Prospectus Regulation"). In other
member states of the EEA which have implemented the Prospectus Regulation in its
national legislation, any offer of Securities may only be made in accordance
with an applicable exemption in the Prospectus Regulation and/or in accordance
with an applicable exemption under a relevant national implementation measure.

In the United Kingdom, this document and any other materials in relation to the
securities described herein is only being distributed to, and is only directed
at, and any investment or investment activity to which this document relates is
available only to, and will be engaged in only with, "qualified investors" who
are (i) persons having professional experience in matters relating to
investments who fall within the definition of "investment professionals" in
Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (the "Order")